{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17940663", "DateCompleted": {"Year": "2008", "Month": "01", "Day": "31"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1995-1892", "JournalIssue": {"Volume": "18", "Issue": "4", "PubDate": {"Year": "2007", "Season": "Jul-Aug"}}, "Title": "Cardiovascular journal of Africa", "ISOAbbreviation": "Cardiovasc J Afr"}, "ArticleTitle": "African traditional medicines for erectile dysfunction: elusive dream or imminent reality?", "Pagination": {"StartPage": "213", "EndPage": "215", "MedlinePgn": "213-5"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Ojewole", "ForeName": "J A", "Initials": "JA"}], "PublicationTypeList": ["Editorial", "Review"]}, "MedlineJournalInfo": {"Country": "South Africa", "MedlineTA": "Cardiovasc J Afr", "NlmUniqueID": "101313864", "ISSNLinking": "1015-9657"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phosphodiesterase Inhibitors"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Africa"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Erectile Dysfunction"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Medicine, African Traditional"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Phosphodiesterase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54\u201361.", "ArticleIdList": ["8254833"]}, {"Citation": "Laumann EO, Paik A, Rosen RC. Sexual dysfunction in United States: prevalence and predictors. J Am Med Assoc. 1999;281:537\u2013544.", "ArticleIdList": ["10022110"]}, {"Citation": "et al. Impotence. NIH consensus development panel on impotence. J Am Med Assoc. 1993;270:83\u201390.", "ArticleIdList": ["8510302"]}, {"Citation": "Golijanin D, Singer E, Davis R, Bhatt S, Seftel A, Dogra V. Doppler evaluation of erectile dysfunction \u2013 Part 1. Int J Impot Res. 2007;19:37\u201342.", "ArticleIdList": ["16625230"]}, {"Citation": "Conti CR, Pepine CJ, Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischaemic heart disease. Am J Cardiol. 1999;83:29C\u201334C.", "ArticleIdList": ["10078540"]}, {"Citation": "Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes. J Am Med Assoc. 1999;281:421\u2013426.", "ArticleIdList": ["9952201"]}, {"Citation": "Derry FA, Dinsmore WW, Fraser M. et al. Efficacy and safety of oral sildenafil (ViagraTM) in men with erectile dysfunction caused by spinal cord injury. Neurology. 1998;51:1629\u20131633.", "ArticleIdList": ["9855514"]}, {"Citation": "Zusman RM, Morales A, Glasser DB, Osterloh IH. Overall cardiovascular profile of sildenafil citrate. Am J Cardiol. 1999;83:35C\u201344C.", "ArticleIdList": ["10078541"]}, {"Citation": "Blumentals WA, Gomez-Caminero A, Joo S, Vannappaggari V. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res. 2004;16:350\u2013353.", "ArticleIdList": ["14985780"]}, {"Citation": "Sesti C, Florio V, Johnson EG, Kloner RA. The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size. Int J Impot Res. 2007;19:55\u201361.", "ArticleIdList": ["16858368"]}, {"Citation": "Aversa A, Pili M, Fabbri A, Spera E, Spera G. Erectyle dysfunction: expectations beyond phosphodiesterase type-5 inhibition. J Endoctrinol Invest. 2004;27:192\u2013206.", "ArticleIdList": ["15129818"]}, {"Citation": "Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized, controlled trial. Urology. 2003;62:121\u2013125.", "ArticleIdList": ["12837435"]}, {"Citation": "Kloner RA. Cardiovascular effects of 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation. 2004;110:3149\u20133155.", "ArticleIdList": ["15533876"]}, {"Citation": "Rosano GMC, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol. 2005;47:214\u2013222.", "ArticleIdList": ["15661417"]}, {"Citation": "Jarow JP, Burnett AL, Geringer AM. Clinical efficacy of sildenafil citrate based on aetiology and response to prior treatment. Am J Urol. 1999;162:722\u2013725.", "ArticleIdList": ["10458352"]}, {"Citation": "Rajfer J, Aliotta PJ, Steidle CP, Fitch WP, Zhao Y, Yu A. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, doubleblind, placebo-controlled study in the US. Int J Impot Res. 2007;19:95\u2013103.", "ArticleIdList": ["16871272"]}, {"Citation": "Kukrejia RC, Ockaili R, Salloum F, Yin C, Hwakins J, Das A. et al. Cardioprotection with phosphodiesterase-5 inhibition \u2013 a novel preconditioning strategy. J Mol Cell Cardiol. 2003;36:165\u2013173.", "ArticleIdList": ["14871543"]}, {"Citation": "Bryant AT. Zulu Medicine and Medicine-Men. Cape Town: Centaur Struik; 1966."}, {"Citation": "Hutchings A, Scott AH, Lewis G, Cunningham A. Zulu Medicinal Plants: An Inventory. Pietermaritzburg: University of Natal Press; 1996. pp. 145\u2013146."}, {"Citation": "Drewes SE, Horn MM, Munro OQ, Dhlamini JTB, Meyer JJM, Rakuambo NC. Pyrano-isoflavones with erectile-dysfunction activity from Eriosema kraussianum. Phytochemistry. 2002;59:739\u2013747.", "ArticleIdList": ["11909631"]}, {"Citation": "Drewes SE, George J, Khan F. Recent findings on natural products with erectile-dysfunction activity. Phytochemistry. 2003;62:1019\u20131025.", "ArticleIdList": ["12591255"]}, {"Citation": "Ojewole JAO, Drewes SE, Khan F. Vasodilatory and hypoglycaemic effects of two pyrano-isoflavone extractives from Eriosema kraussianum N.E. Br. [Fabaceae] rootstock in experimental rat models. Phytochemistry. 2006;67:610\u2013617.", "ArticleIdList": ["16434072"]}]}], "History": [{"Year": "2007", "Month": "10", "Day": "18", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "2", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "10", "Day": "18", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "7", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17940663", "PMC4170225"]}}], "PubmedBookArticle": []}